Renalytix plc (RNLXY) stock
RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)
Close on Oct 19, 2026Market cap $375.75MP/E –Yield –
Renalytix operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Renalytix's operating cash flow for the twelve months ending Sep 30, 2024 was -$24.44M. For fiscal 2024 it was -$30.11M. The highest annual figure on record is -$6.16M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | -$30.11M | – |
| FY2023 | Jun 30, 2023 | -$34.09M | – |
| FY2022 | Jun 30, 2022 | -$45.92M | – |
| FY2021 | Jun 30, 2021 | -$28.40M | – |
| FY2020 | Jun 30, 2020 | -$9.52M | – |
| FY2019 | Jun 30, 2019 | -$6.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$3.84M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$7.83M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$4.86M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$7.92M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$9.50M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$8.63M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$10.10M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$8.23M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$7.12M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$14.17M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$7.02M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$14.24M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$10.49M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$5.10M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$4.73M | – |
See a number that looks wrong?